CLYM
Climb Bio, Inc.
-0.05 (-0.35%)14.06USD268K成交股數808M市值–本益比(近四季)99.3股價營收比–營收年增(近四季)2026-11-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 9.7M | 9.4M | 9.1M | 6.6M | 17.3M | 6.0M | 6.2M | 1.0M | 1.1M | 2.9M | 3.7M | 5.7M |
| 銷售管理費用 | 5.6M | 5.8M | 5.8M | 4.1M | 5.7M | 5.0M | 5.5M | 3.7M | 1.9M | 2.1M | 3.0M | 17.7M |
| 營業利益 | −15.4M-33% | −15.2M+39% | −14.9M+27% | −10.7M-81% | −23.0M+666% | −10.9M+118% | −11.7M+75% | −56.4M+141% | −3.0M | −5.0M | −6.7M | −23.4M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −13.5M-35% | −13.7M+63% | −12.9M+45% | −8.7M-84% | −20.8M+1125% | −8.4M+112% | −8.9M+70% | −54.9M+146% | −1.7M | −4.0M | −5.2M | −22.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.18-42% | -0.20-143% | -0.19+46% | -0.13-93% | -0.31+417% | 0.47-413% | -0.13-32% | -1.81+115% | -0.06 | -0.15 | -0.19 | -0.84 |
| 稀釋股數 | 76.2M | 68.2M | 68.0M | 67.6M | 67.5M | 48.2M | 67.0M | 30.3M | 27.6M | 27.1M | 26.8M | 26.5M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 44.1M | 8.4M | 25.8M | 22.7M | 29.0M | 87.2M | 146M | 223M | 105M | 57.4M | 25.3M | 34.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 246M | 152M | 182M | 192M | 201M | 217M | 222M | 226M | 109M | 113M | 116M | 122M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 6.7M | 4.3M | 5.3M | 6.6M | 7.4M | 5.3M | 3.4M | 3.7M | 3.0M | 3.0M | 3.8M | 5.2M |
| 股東權益 | 240M | 148M | 177M | 186M | 193M | 212M | 219M | 222M | 106M | 110M | 113M | 117M |
| 負債比 | 2.7% | 2.8% | 2.9% | 3.4% | 3.7% | 2.4% | 1.5% | 1.7% | 2.7% | 2.7% | 3.2% | 4.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −14.4M | – | – | −15.4M+748% | – | – | – | −1.8M | – | – | −15.2M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 38K | – | – | 0.00 | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −59.9M | –% | -0.88 | −54.5M |
| FY2024 | 8.1M | +76.0% | −73.9M | -908.7% | -1.53 | −15.6M |
| FY2023 | 4.6M | – | −35.1M | -760.2% | -1.30 | −20.6M |
| FY2022 | – | – | −45.2M | –% | -1.72 | – |
| FY2021 | – | – | −47.5M | –% | -4.24 | – |
| FY2020 | – | – | −20.7M | –% | -10.49 | – |